Introductory Chapter: Primary Concept of Hypoxia and Anoxia by Bagali, Shrilaxmi et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 1
Introductory Chapter: Primary Concept of Hypoxia and
Anoxia
Shrilaxmi Bagali, Gavishsidappa A. Hadimani,
Mallanagouda S. Biradar and Kusal K. Das
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/intechopen.80270
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, 
distribution, and reproduction in any medium, provided the original work is properly cited. 
     
ll  S.  ir r  s l .  s
Additional infor ation is available at the end of the chapter
1. Introduction
Hypoxia is a pathological condition classified as generalized hypoxia and tissue hypoxia. It 
is well known that arterial oxygen saturation is a part of the normal physiology. A disparity 
between oxygen supply and its demand at the cellular level may result in a hypoxic con-
dition. Hypoxia in which there is complete deprivation of oxygen supply is referred to as 
anoxia. Hypoxia belongs to the most grave factors that can directly impair the function of 
metabolic pathways in the animal cell. These studies dealt mostly with changes in the struc-
ture of pulmonary vessels. Normally, PO2 values of −100 Torr in the alveoli of the lungs to 
less than 10 Torr in tissues such as the medulla of the kidney and the retina in healthy humans 
are considered as the range of physiological oxygen levels within the tissues of the body 
[1]. Hypoxia, which occurs when oxygen levels in the microenvironment of a cell, tissue, or 
organism are reduced relative to the normal physiological state, is associated with a range of 
physiological and pathophysiological processes [2].
Hypoxia may limit the energy reserves or scope for augmentation and bustle of an organism, 
it may cause an organism to alter its behavior and/or it may limit the tolerance of an organism 
to other environmental challenges [3].
2. Hypoxia pathophysiology
Tissue hypoxia is also associated with a diverse and wide range of pathophysiological processes 
including (but not limited to) vascular disease, chronic inflammation, and cancer [3]. In vascular 
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diseases such as atherosclerosis and stroke, vascular occlusion leads to acute or chronic tissue 
ischemia with resultant hypoxia [4]. In cancer, the growth of a tumor away from the local blood 
supply eventually leads to tumor hypoxia [2]. Hypoxia induces ischemia, hemorrhage, and 
stroke and found to cause systemic inflammation response syndrome (SIRS), multiple organ 
dysfunctions (MOD), and multiple organ failure [5].
Hypoxia has been shown to lead to increases in intracellular free calcium concentration (Ca2+), 
5-lipoxygenase, lipid peroxidation, cyclooxygenase (COX), constitutive nitric oxide synthase 
(cNOS), leukotriene B4 (LTB4), prostaglandin E2 (PGE2), interleukins, tumor necrosis factor-α 
(TNF-α), caspases, complement activation, Kruppel-like factor 6 (KLF6), inducible nitric 
oxide synthase (iNOS), heat shock protein 70 kDa (HSP-70), and hypoxia-inducible factor-1α 
(HIF-1α). The sequence of their occurrence provides the useful information for studying the 
mechanisms underlying the hypoxia-induced injury as well as therapeutic targets to prevent 
or ameliorate the injury [6, 7].
3. Discovery of HIF-1
Before HIF-1 was found, HRE had been identified in the 3′-enhancer region of the erythropoietin 
gene, whose transcription is up-regulated by more than 100-fold by severe hypoxia. Hypoxia, or 
Figure 1. Schematic representation of the cell signaling events leading to ubiquitin-mediated degradation of hypoxia-
inducible factor 1α (HIF-1α) and hypoxia-mediated expression of VEGF and EPO protein. VEGF, vascular endothelial 
growth factor; EPO, erythropoietin; MAPK, mitogen-activated protein kinase.
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inadequate oxygenation, causes various responses within the body. Its effects are usually medi-
ated via the activation of hypoxia inducible factor 1 (HIF-1). HIF-1 activation can lead to up-
regulation of various genes such as erythropoietin and growth factors that help tissues adjust to 
the decreasing oxygen availability. Another key molecule within this hypoxia-induced response 
is the presence of nitric oxide [NO]. NO is a ubiquitous gaseous molecule within our body. It 
is synthesized by nitric oxide synthases (NOS) and its release can be stimulated as a result of 
inflammatory responses, sympathetic activation and drop in oxygen levels [5]. Increase of HIF-1 
translocates to the nucleus, dimerizes with the alpha subunit, and activates the transcription of a 
number of target genes displaying an HRE shape. Nuclear localization signal (NLS) domains in 
the alpha and beta subunit confer autonomous translocation into the nucleus 248 [8–10].
One group of HIF-1 target genes is involved in the adaptive response facilitating oxygen 
delivery to oxygen-deprived tissues. It includes, for example, genes coding for erythropoietin, 
VEGF-A, and inducible NOS (iNOS) [11, 12] (Figure 1).
4. Hypoxia and oxidative stress
During normoxia, about 2–3% of oxygen consumed by the mitochondria is incompletely 
reduced yielding reactive oxygen species (ROS) [13]. The mitochondrial ROS route to the 
cytosol and at low to moderate concentrations act as signaling molecules for a number of 
biological functions like cell growth, differentiation and metabolism and immune functions. 
Although at high concentrations, they can adversely modify the cell components like lipids, 
proteins, and DNA. However, the cells are well equipped with antioxidants that are capable 
of mounting an adequate antioxidant defense against ROS. Oxidative stress results when 
there is a shift in the balance between the oxidants and antioxidants in favor of oxidants 
disrupting redox signaling and control and/or inducing molecular damage [14]. In addition 
to a host of factors, both low and high oxygen levels are capable of inducing increased ROS 
formation and ultimately oxidative stress. Since oxygen is essential for formation of all ROS 
several controversies exist, it appears paradoxical for increased ROS formation in low oxygen 
microenvironment like hypoxia. However, there is enough evidence in support of increased 
ROS formation and oxidative stress in hypoxia.
4.1. Hypoxia and mitochondrial ROS generation
Mitochondria have been considered the main source of ROS generation (particularly H2O2) dur-ing hypoxia. Bell et al. have demonstrated a dose-dependent relationship between ROS and 
available oxygen levels with an increase in intracellular ROS with increasing severity of hypoxia 
[15]. During mitochondrial respiration, electrons from NADH and FADH2 are transferred suc-cessively through several electron carrier molecules of the electron transport chain (respira-
tory chain). The electron transport chain consists of series of proteins and organic molecules 
located in the inner mitochondrial membrane (IMM) and organized as four membrane bound 
complexes (complex I–IV) which generate a proton gradient across the inner mitochondrial 
membrane and two mobile carriers—cytochrome c and Ubiquinone (coenzyme Q) and a ATP 
synthase (complex V, F1F0-ATPase) that uses the proton gradient for ATP synthesis. Complex 
I (NADH dehydrogenase) and complex II (succinate dehydrogenase) transfer electrons from 
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NADH and FADH2, respectively, to coenzyme Q (ubiquinone). Ubiquinone can accept one 
electron to form ubisemiquinone or two electrons to form ubiquinol. Because of its lipid solubil-
ity and small size, it is freely mobile within the lipid bilayer of the inner mitochondrial mem-
brane (IMM). Reduced coenzyme Q further feeds the electrons to complex III of the electron 
transport chain (ETC). Complex III pushes the electrons to complex IV (cytochrome oxidase) 
via cytochrome c, second mobile carrier of the ETC. At this stage, complex III plays a crucial 
role of transferring single electrons sequentially to cytochrome c and complex IV since they can 
accept single electrons at a time unlike complex I and complex II [16]. Complex IV transfers 
the electrons from cytochrome c to final electron acceptor oxygen which is reduced to water in 
the process. As the electrons travel through ETC, they move downhill from a higher to lower 
energy level. The energy released in this downhill movement of electrons is used to pump 
protons (H+) (by complexes I, III, and IV) from the mitochondrial matrix to the inter membrane 
space creating a proton gradient. The generated proton gradient drives formation of energy 
in the form of ATP from ADP and Pi by ATP synthase. During the ETC, ROS are produced at 
complex I, II, and III. Complex I and II produce ROS only into the matrix, while complex III 
produces ROS on both sides of the inner mitochondrial membrane [13]. Complex III is con-
sidered as an important source of ROS during hypoxia [17]. Crucial role of complex III in ROS 
formation in hypoxia necessitates a greater understanding of its role in ETC. Mitochondrial 
complex III also referred to as cytochrome bc1 complex (cyt bc1 or bc1) or ubiquinol cytochrome c oxidoreductase is a dimer with each monomer made up of 11 protein subunits encoded by 
mitochondrial and nuclear genes [16]. Complex III has three important subunits with known 
electron transport activity—binuclear Rieske Fe-S protein (2Fe-2S cluster), bis-heme cyto-
chrome b, and cytochrome c1 [18]. Cytochrome b contains two heme groups. Of the two heme groups, one is low potential heme (bL) located near the outer surface of the inner mitochondrial membrane and the second high potential heme (bH) at the center of the membrane about 20 Å from bL [19]. The complex III has two separate ubiquinol and ubiquinone binding sites—Qo and Qi. Qo is located on the P (positive) side (outer surface) of the inner mitochondrial mem-
brane and is ubiquinol oxidation site. Qi is located on the N (negative) side (close to the matrix) 
of the inner mitochondrial membrane and is the ubiquinone reduction site [20]. Complex III 
performs an important function of transfer of single electrons sequentially to cytochrome c and 
then to cytochrome IV since they can accept single electrons at a time unlike complex I and 
complex II by a cycle called Q cycle (Figure 2a and b). Q cycle begins with the binding of first 
molecule of ubiquinol to Qo site and ubiquinone at Qi site of complex III. The two electrons of 
ubiquinol follow two separate paths within complex III. One of the electrons from ubiquinol 
(yielding ubisemiquinone) is transferred to Rieske Iron-Sulfur protein to cytochrome c1 and 
finally to cytochrome c. The second electron from ubisemiquinone is transferred to cytochrome 
b and subsequently to ubiquinone bound at the Qi site of complex III converting ubiquinone to 
ubisemiquinone. Yet another ubiquinol binds at the Qo site with electron following the Rieske 
Iron-Sulfur, cytochrome c1, cytochrome c pathway, and the second electron via cytochrome b reduces the ubisemiquinone at the Qi site to regenerate ubiquinol. Thus, one Q cycle involves 
oxidation of two ubiquinol molecules to ubiquinone with regeneration of one ubiquinol mol-
ecule and transfer of four protons from the intermembrane space from the matrix [21].
Superoxide can be generated at Qo and Qi sites at complex III by one electron reduction of oxygen 
to superoxide (Figure 2a and b) [21]. Ubisemiquinone that is formed repeatedly at Qo and Qi sites 
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of complex III is the site of ROS formation in hypoxia. The molecular oxygen that is lipophilic is 
dissolved in the hydrophobic environment within the membrane is highly electrophilic and can 
potentially capture electrons from ubisemiquinone forming superoxide radical [16]. Superoxide 
generated at Qo site is released into the intermembrane space and that generated at Qi site is 
Figure 2. Schematic diagram depicting the Q-cycle at complex III of the mitochondrial electron transport chain and the 
generation of superoxide and H2O2 radicals at Qo and Qi sites of complex III.
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released to the mitochondrial matrix. Superoxide is an important source of H2O2 during hypoxia. Superoxide can be dismutated to H2O2 in the matrix by Cu, Zn-SOD and in the intermembrane space by Mn-SOD [18]. Hydrogen peroxide can travel to the cytosol via the membrane aquaporin 
channels [22]. Superoxide may also enter the cytosol through voltage-dependent anion channels 
(VDACs) [23]. The mechanism by which hypoxia increases ROS generation are poorly under-
stood; however, several hypothesis have been proposed like O2-dependent structural changes that prolong the lifetime of ubisemiquinone (“semiquinone lifetime” hypothesis), increase in the 
accessibility of O2 to a site where single electrons can be captured (“oxygen access” hypoth-esis) or enhancement of the directional escape of superoxide to the intermembrane space versus 
matrix compartments (“vectoral transport” hypothesis) [16, 21].
The ROS produced can either participate in cell signaling or induce irreversible cellular dam-
age and death [24]. There is substantial evidence to suggest the role of ROS produced at com-
plex III of ETC in hypoxia signaling by stabilizing HIF-1α by preventing its hydroxylation by 
prolyl hydroxylases in low-oxygen microenvironment. This allows HIF-1α translocation to 
the nucleus and dimerization with HIF-1β initiating transcription of target genes (Figure 3) 
[17]. Prolyl hydroxylases (PHDs) belong to a family of mixed function oxidases involved 
in the hydroxylation of proline residues of HIF-1α that signals it for degradation. These 
enzymes require 2-oxoglutarate (α-ketoglutarate) and oxygen as substrates and non-heme 
iron as a cofactor [16]. The activities of PHDs have been extremely sensitive to inhibition by 
ROS although the mechanisms by which the ROS alter the activity of PHDs are unknown. 
However, the following hypotheses have been put forward: (1) possible oxidation of ferrous 
iron (Fe2+) to ferric iron (Fe3+) forbidding the mandatory binding of ferrous iron to prolyl 
hydroxylases; (2) recruiting ascorbate for free radical scavenging making it unavailable for 
Figure 3. Schematic diagram depicting the various sources of ROD and the biological effects of ROS.
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reducing ferric iron or probably by preventing direct binding of ascorbate to prolyl hydroxy-
lase; (3) altering the concentrations of 2-oxoglutarate and succinate that might also have an 
prolyl hydroxylase activity [16, 25, 26]. Paddenberg et al. demonstrated a role of complex II 
of the electron transport chain in hypoxia-induced ROS generation particularly in the pulmo-
nary vasculature. Complex II is the smallest of the protein complexes of the ETC located on 
the matrix side of the inner mitochondrial membrane. Under normoxia, this complex oxidizes 
succinate to fumarate meanwhile transferring two electrons to ubiquinone and reducing it to 
ubiquinol. During hypoxia, complex II switches its function from succinate dehydrogenase to 
fumarate reductase changing the direction of electron flow from ubiquinol to fumarate (fuma-
rate accepting as electron acceptor), thereby generating ROS and accumulating succinate [27].
5. Conclusion
Hypoxia exposure induces generation of ROS (reactive oxygen species) and increases expres-
sion of p53, NF-kβ, AP-1, MAPK, and HIF-1α. The increase in expression of all these tran-
scription factors leads to either cellular adaptation or cell death. The mechanisms by which 
mammalian cells adapt to acute and chronic alteration of oxygen tension are extremely 
important to understand the exact homeostasis regulation to counteract hypoxia-induced cell 
damage as therapeutic strategy.
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